Company: MDXG
Filing Date: 2025-07-30
Form Type: 10-Q
Source: 0001376339-25-000085
Chunk: 12

Company: MIMEDX GROUP, INC.
Filing Date: 2025-07-30
Form: 10-Q
Item: Item 1A
Chunk 12
---
Item 1A. Risk Factors 

There have been no material changes to the Company’s risk factors included in its 2024 Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Insider Trading Arrangements and Policies

During the three months ended June 30, 2025, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

Item 6. Exhibits

ExhibitNumberDescription31.1 #Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.31.2 #Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.32.1 #Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.32.2 #Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.101.INS #XBRL Instance Document101.SCH #XBRL Taxonomy Extension Schema Document101.CAL #XBRL Taxonomy Extension Calculation Linkbase Document101.DEF #XBRL Taxonomy Extension Definition Linkbase Document101.LAB #XBRL Taxonomy Extension Label Linkbase Document101.PRE #XBRL Taxonomy Extension Presentation Linkbase Document

#Filed or furnished herewith

SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

25

July 30, 2025MIMEDX GROUP, INC.    By:/s/ Doug Rice  Doug Rice  Chief Financial Officer(duly authorized officer)

26